Insiders · GFOR

GFOR insider transactions

Graf Acquisition Corp. IV (GFOR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

GFOR insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Graf Acquisition Corp. IV, latest first. Follow anyone to get their next filing.

• Kathleen D. ScottDirector, since September 2023
• Yong Man KimCSO and CIO, since September 2023
• Paul Y. SongChief Executive Officer, Director, since September 2023+$2,481
• Pierre GagnonChief Operating Officer, since September 2023
• Michael KlowdenDirector, since September 2023
• Sangwoo ParkDirector, 10% owner, since September 2023
• James A GrafOfficer+$2,240
• Alana B. McNultyDirector, since September 2023
• Graf Acquisition Partners IV LLC10% owner
• Sterling CrossOfficer, since May 2022

Recent Form 3, 4, and 5 filings for GFOR

• 999d
  SEC Form 4 filed by Scott Kathleen D.

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 999d
  SEC Form 4 filed by Kim Yong Man

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 999d
  SEC Form 4 filed by Song Paul Y.

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 999d
  SEC Form 4 filed by Gagnon Pierre

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 999d
  SEC Form 4 filed by Klowden Michael

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1060d
  Park Sangwoo gifted 2,500,000 shares (SEC Form 4)

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1068d
  Song Paul Y. bought $500 worth of shares (151 units at $3.30), increasing direct ownership by 0.09% to 171,121 units (SEC Form 4)

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1071d
  Song Paul Y. bought $850 worth of shares (268 units at $3.17), increasing direct ownership by 0.16% to 170,969 units (SEC Form 4)

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1071d
  Graf James A bought $2,172 worth of shares (670 units at $3.24), increasing direct ownership by 2,913% to 693 units (SEC Form 4)

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1078d
  Song Paul Y. bought $701 worth of shares (244 units at $2.88), increasing direct ownership by 0.14% to 170,701 units (SEC Form 4)

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1083d
  Graf James A bought $67 worth of shares (23 units at $2.93) (SEC Form 4)

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1083d
  Song Paul Y. bought $430 worth of shares (153 units at $2.82), increasing direct ownership by 0.09% to 170,458 units (SEC Form 4)

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1127d
  SEC Form 3 filed by new insider Klowden Michael

  3 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1127d
  SEC Form 3 filed by new insider Scott Kathleen D.

  3 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1127d
  SEC Form 3 filed by new insider Mcnulty Alana B.

  3 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1127d
  SEC Form 3 filed by new insider Gagnon Pierre

  3 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1127d
  New insider Kim Yong Man claimed ownership of 28,384 shares (SEC Form 3)

  3 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1127d
  New insider Song Paul Y. claimed ownership of 170,305 shares (SEC Form 3)

  3 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1127d
  New insider Park Sangwoo claimed ownership of 13,017,990 shares (SEC Form 3)

  3 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1133d
  Graf Acquisition Partners Iv Llc disposed of 1,773,631 shares (SEC Form 4)

  4 - NKGen Biotech, Inc. (0001845459) (Issuer)
• 1643d
  SEC Form 3 filed by new insider Cross Sterling

  3 - Graf Acquisition Corp. IV (0001845459) (Issuer)